DNA sequence variations in the prolyl isomerase Pin1 gene and Alzheimer's disease

被引:14
作者
Poli, M
Gatta, LB
Dominici, R
Lovati, C
Mariani, C
Albertini, A
Finazzi, D
机构
[1] Univ Brescia, Fac Med, Biochem Sect, I-25123 Brescia, Italy
[2] L Sacco Hosp Vialba, Lab Anal Chim Clin, Milan, Italy
[3] Univ Milan, L Sacco Hosp, Neurol Unit, Milan, Italy
[4] Spedali Civil Brescia, Terzo Lab Anal Chim Clin, I-25125 Brescia, Italy
关键词
Alzheimer's disease; Pin1; tau; SNP; DHPLC;
D O I
10.1016/j.neulet.2005.07.027
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Senile plaques and neurofibrillary tangles (NFT) are the prominent lesions in the brain of Alzheimer's disease (AD) patients. NFT are mainly composed of an abnormally phosphorylated form of tau protein, which has lost its function to bind microtubules and promote their assembly. Tau hyperphosphorylation critically decreases tau function and precedes neurodegeneration. The majority of tau phosphorylation sites are Ser/Thr-Pro motifs, which are known to exist in two distinct. cis and trans conformations. The prolyl isomerase Pin1 catalyses the conversion of those conformations. Pin1 binds to tau specifically at the Thr231-Pro site and restores tau function, either by inducing conformational changes or facilitating dephosphorylation. It has been shown that Pin1 expression levels inversely correlate with the predicted vulnerability of different brain areas to neurodegeneration and soluble Pin1 is depleted in neurons from AD brains; furthermore, Pin1 knock-out mice develop signs and symptoms of tau-related pathologies late in life. It seems that Pin1 plays an important role in maintaining tau function, thereby preserving neuronal homeostasis and preventing age-dependent neurodegeneration. DNA sequence variations in Pin1 gene may affect its expression level or function and influence the individual risk for developing AD. We screened by denaturing high performance liquid chromatography the genomic DNA of 120 AD subjects and 134 age-matched controls and we found very few and rare sequence variations in the promoter region and in exons 2 and 3. We conclude that Pin1 is a very well conserved gene, whose rare nucleotide variations have no effect on the individual genetic risk for AD. (C) 2005 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:66 / 70
页数:5
相关论文
共 35 条
[1]   Abnormal phosphorylation of tan and the mechanism of Alzheimer neurofibrillary degeneration: Sequestration of microtubule-associated proteins 1 and 2 and the disassembly of microtubules by the abnormal tau [J].
Alonso, AD ;
GrundkeIqbal, I ;
Barra, HS ;
Iqbal, K .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (01) :298-303
[2]   Alzheimer's disease hyperphosphorylated tau sequesters normal tau into tangles of filaments and disassembles microtubules [J].
Alonso, AD ;
GrundkeIqbal, I ;
Iqbal, K .
NATURE MEDICINE, 1996, 2 (07) :783-787
[3]   ACCUMULATION OF ABNORMALLY PHOSPHORYLATED-TAU PRECEDES THE FORMATION OF NEUROFIBRILLARY TANGLES IN ALZHEIMERS-DISEASE [J].
BANCHER, C ;
BRUNNER, C ;
LASSMANN, H ;
BUDKA, H ;
JELLINGER, K ;
WICHE, G ;
SEITELBERGER, F ;
GRUNDKEIQBAL, I ;
IQBAL, K ;
WISNIEWSKI, HM .
BRAIN RESEARCH, 1989, 477 (1-2) :90-99
[4]   Prevalent overexpression of prolyl isomerase Pin1 in human cancers [J].
Bao, L ;
Kimzey, A ;
Sauter, G ;
Sowadski, JM ;
Lu, KP ;
Wang, DG .
AMERICAN JOURNAL OF PATHOLOGY, 2004, 164 (05) :1727-1737
[5]   Regulated phosphorylation and dephosphorylation of tau protein: Effects on microtubule interaction, intracellular trafficking and neurodegeneration [J].
Billingsley, ML ;
Kincaid, RL .
BIOCHEMICAL JOURNAL, 1997, 323 :577-591
[6]   Tau alteration and neuronal degeneration in tauopathies: mechanisms and models [J].
Brandt, R ;
Hundelt, M ;
Shahani, N .
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2005, 1739 (2-3) :331-354
[7]   The structural basis for specificity of substrate and recruitment peptides for cyclin-dependent kinases [J].
Brown, NR ;
Noble, MEM ;
Endicott, JA ;
Johnson, LN .
NATURE CELL BIOLOGY, 1999, 1 (07) :438-443
[8]   PHOSPHATASE-ACTIVITY TOWARD ABNORMALLY PHOSPHORYLATED-TAU - DECREASE IN ALZHEIMER-DISEASE BRAIN [J].
GONG, CX ;
SHAIKH, S ;
WANG, JZ ;
ZAIDI, T ;
GRUNDKEIQBAL, I ;
IQBAL, K .
JOURNAL OF NEUROCHEMISTRY, 1995, 65 (02) :732-738
[9]   ABNORMAL PHOSPHORYLATION OF THE MICROTUBULE-ASSOCIATED PROTEIN-TAU (TAU) IN ALZHEIMER CYTOSKELETAL PATHOLOGY [J].
GRUNDKEIQBAL, I ;
IQBAL, K ;
TUNG, YC ;
QUINLAN, M ;
WISNIEWSKI, HM ;
BINDER, LI .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1986, 83 (13) :4913-4917
[10]   Neurofibrillary degeneration of the Alzheimer-type:: an alternate pathway to neuronal apoptosis? [J].
Hamdane, M ;
Delobel, P ;
Sambo, AV ;
Smet, C ;
Bégard, S ;
Violleau, A ;
Landrieu, I ;
Delacourte, A ;
Lippens, G ;
Flament, S ;
Buée, L .
BIOCHEMICAL PHARMACOLOGY, 2003, 66 (08) :1619-1625